Treatment of acute respiratory distress syndrome in secondary surfactant deficiency in neonates
Keywords:
acute respiratory distress syndrome, secondary surfactant deficiency, neonates
Abstract
In this report we present data of three premature infants who received 1 to 2 doses ofsurfactant for an acute respiratory deterioration and after initial surfactants treatment for RDS.
References
1. Mari E. Acute respiratory diseases. In: Gerald BM, Chandra
LG, editors. Handbook of neonatal intensive care. 6 th ed.
USA: Mosby; 2006. p. 595-698.
2. Taeusch HW. Treatment of acute (adult) respiratory distress
syndromethe holy grail of surfactant therapy. Biol Neonate
2000;77:2-8.
3. Lopez-Herce De Lucas N, Carrillo A, Bustinza A, Moral R.
Surfactant treatment for acute respiratory distress syndrome.
Arch Dis Child 1999;80:248-52.
4. Jobe AH. Pathophysiology of respiratory distress syndrome.
In: Polin PA, Fox WW, editors. Fetal and neonatal physiology
vol. 2 Philadelpia: WB Saunders Company; 1992. p. 995–
1001.
5. Egbert Herting, Olaf Gefeller, Matthias Land, Loekie van
Sonderen, Karsten Harms, Bengt Robertson, et al. Surfactant
treatment of neonates with respiratory failure and group B
streptococcal infection. Pediatrics 2000;106:957-64.
6. Harms K, Herting E. Successful surfactant replacement
therapy in two infants with ARDS due to chlamydial
pneumonia. Respiration 1994;61:348-52.
7. M Moreno, J López-Herce, C Merello, A Alcaraz, A Carrillo.
Exogenous surfactant therapy for acute respiratory distress
in infancy. Intensive Care Med 1996;22:87-8.
8. Willson DF, Jin Hua Jiao, Bauman LA, Zaritsky A, Craft H,
Dockery K, et al. Calf’s lung surfactant extract in acute
hypoxemic respiratory failure in children. Crit Care Med
1996;24:1316-22.
9. Auten RL, Notter RH, Kendig JW, Davis JM, Shapiro DL.
Surfactant treatment of full-term newborns with severe
respiratory failure. Pediatrics 1991;87:101-7.
10. Richard D, Findlay, H William Taeusch, Frans J Walther.
Surfactant replacement therapy for meconium aspiration
syndrome. Pediatrics 1996;97:48-52.
11. Couser RJ, Ferrara TB, Ebert J, Hoekstra RE, Fangman JJ.
Effect of exogenous surfactant therapy on dynamic
compliance during mechanical breathing in preterm infants
with hyaline membrane disease. J Pediatr 1990;116:119–24.
12. Donald W Thibeault, Sherry M Mabry, Ikechukwu I
Ekekezie, William E Truog. Lung elastic tissue maturation
and perturbations during the evolution of chronic lung
disease. Pediatrics 2000;106:1452-9.
13. Nishina K, Mikawa K, Takao Y, Maekawa N, Obara H. Effects
of exogenous surfactant on acute lung injury induced by
intratracheal instillation of infant formula or human breast
milk in rabbits. Anesthesiology 1999;91:240-52.
14. Kazzi SNJ, Schürch S, McLaughlin KL, Romero R, Janisse
J. Surfactant phospholipids and surface activity among
preterm infants with respiratory distress syndrome who
develop bronchopulmonary dysplasia. Acta Paediatr
2000;89:1218-25.
15. Paresh B Pandit, Michael S Dunn, Edmond N Kelly, Max
Perlman. Surfactant replacement in neonates with early
chronic lung disease. Pediatrics 1995;95:851-4.
16. Zimmermann LJI. Neonatal metabolism of surfactant
phosphatidylcholine: therapeutic implications. In: D Tibboel
E, van der Voort, editors. Intensive care in childhood a
challenge to the future. Germany: Springer; 1996. p. 75–89.
17. Bhutani VK, Abasi S, Long W, Gerdes JS. Pulmonary
mechanics and energetics in preterm infant who had
respiratory distress syndrome treatment with synthetic
surfactant .J Pediatr 1992;120:S18-S24.
18. Doyle LW, Gultom E, Chuang SL, James M, Davis P, Bowman
E. Changing mortality and causes of death in infants 23 – 27
weeks gestation age. J Paediatr Child Health 1999;35:255-9.
19. Long W, Corbet A, Cotton R. A controlled trial of synthetic
surfactant in infants weighing 1250 g or more with respiratory
distress syndrome. The American Exosurf Neonatal Study
Group I, and the Canadian Exosurf Neonatal Study Group.
N Engl J Med 1991;325:1696-703.
20. Kristine, Dharmapuri. Surfactant physiology, metabolism,
function and therapy. In: Shoemakers, Ayres, Grenvik,
Holbrook, editors. Textbook of critical care. Philadelphia:
WB Saunders Company; 2000. p. 1424–32.
LG, editors. Handbook of neonatal intensive care. 6 th ed.
USA: Mosby; 2006. p. 595-698.
2. Taeusch HW. Treatment of acute (adult) respiratory distress
syndromethe holy grail of surfactant therapy. Biol Neonate
2000;77:2-8.
3. Lopez-Herce De Lucas N, Carrillo A, Bustinza A, Moral R.
Surfactant treatment for acute respiratory distress syndrome.
Arch Dis Child 1999;80:248-52.
4. Jobe AH. Pathophysiology of respiratory distress syndrome.
In: Polin PA, Fox WW, editors. Fetal and neonatal physiology
vol. 2 Philadelpia: WB Saunders Company; 1992. p. 995–
1001.
5. Egbert Herting, Olaf Gefeller, Matthias Land, Loekie van
Sonderen, Karsten Harms, Bengt Robertson, et al. Surfactant
treatment of neonates with respiratory failure and group B
streptococcal infection. Pediatrics 2000;106:957-64.
6. Harms K, Herting E. Successful surfactant replacement
therapy in two infants with ARDS due to chlamydial
pneumonia. Respiration 1994;61:348-52.
7. M Moreno, J López-Herce, C Merello, A Alcaraz, A Carrillo.
Exogenous surfactant therapy for acute respiratory distress
in infancy. Intensive Care Med 1996;22:87-8.
8. Willson DF, Jin Hua Jiao, Bauman LA, Zaritsky A, Craft H,
Dockery K, et al. Calf’s lung surfactant extract in acute
hypoxemic respiratory failure in children. Crit Care Med
1996;24:1316-22.
9. Auten RL, Notter RH, Kendig JW, Davis JM, Shapiro DL.
Surfactant treatment of full-term newborns with severe
respiratory failure. Pediatrics 1991;87:101-7.
10. Richard D, Findlay, H William Taeusch, Frans J Walther.
Surfactant replacement therapy for meconium aspiration
syndrome. Pediatrics 1996;97:48-52.
11. Couser RJ, Ferrara TB, Ebert J, Hoekstra RE, Fangman JJ.
Effect of exogenous surfactant therapy on dynamic
compliance during mechanical breathing in preterm infants
with hyaline membrane disease. J Pediatr 1990;116:119–24.
12. Donald W Thibeault, Sherry M Mabry, Ikechukwu I
Ekekezie, William E Truog. Lung elastic tissue maturation
and perturbations during the evolution of chronic lung
disease. Pediatrics 2000;106:1452-9.
13. Nishina K, Mikawa K, Takao Y, Maekawa N, Obara H. Effects
of exogenous surfactant on acute lung injury induced by
intratracheal instillation of infant formula or human breast
milk in rabbits. Anesthesiology 1999;91:240-52.
14. Kazzi SNJ, Schürch S, McLaughlin KL, Romero R, Janisse
J. Surfactant phospholipids and surface activity among
preterm infants with respiratory distress syndrome who
develop bronchopulmonary dysplasia. Acta Paediatr
2000;89:1218-25.
15. Paresh B Pandit, Michael S Dunn, Edmond N Kelly, Max
Perlman. Surfactant replacement in neonates with early
chronic lung disease. Pediatrics 1995;95:851-4.
16. Zimmermann LJI. Neonatal metabolism of surfactant
phosphatidylcholine: therapeutic implications. In: D Tibboel
E, van der Voort, editors. Intensive care in childhood a
challenge to the future. Germany: Springer; 1996. p. 75–89.
17. Bhutani VK, Abasi S, Long W, Gerdes JS. Pulmonary
mechanics and energetics in preterm infant who had
respiratory distress syndrome treatment with synthetic
surfactant .J Pediatr 1992;120:S18-S24.
18. Doyle LW, Gultom E, Chuang SL, James M, Davis P, Bowman
E. Changing mortality and causes of death in infants 23 – 27
weeks gestation age. J Paediatr Child Health 1999;35:255-9.
19. Long W, Corbet A, Cotton R. A controlled trial of synthetic
surfactant in infants weighing 1250 g or more with respiratory
distress syndrome. The American Exosurf Neonatal Study
Group I, and the Canadian Exosurf Neonatal Study Group.
N Engl J Med 1991;325:1696-703.
20. Kristine, Dharmapuri. Surfactant physiology, metabolism,
function and therapy. In: Shoemakers, Ayres, Grenvik,
Holbrook, editors. Textbook of critical care. Philadelphia:
WB Saunders Company; 2000. p. 1424–32.
Published
2016-09-24
How to Cite
1.
Samudro H, Winarno W. Treatment of acute respiratory distress syndrome in secondary surfactant deficiency in neonates. PI [Internet]. 24Sep.2016 [cited 13Nov.2024];47(6):303-. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/436
Section
Case Report
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Received 2016-09-02
Accepted 2016-09-02
Published 2016-09-24
Accepted 2016-09-02
Published 2016-09-24
